Novavax Vaccine

• Vaccine maker Novavax, despite concerns for its future, to maintain partnership with Ottawa

  In an effort to get COVID-19 vaccines made in Canada, the federal government announced in February 2021 a deal between with Novavax to begin producing its vaccine in Montreal. 

  Health

  Mar 2
  
• Novavax shares plunge after COVID-19 vaccine maker raises doubts over its future

  Novavax — whose COVID-19 vaccine is its only marketed product after 35 years in business — on Tuesday flagged significant uncertainty around its 2023 revenue.

  World

  Mar 1
  
• Advertisement
• U.S. FDA approves new Novavax COVID-19 shot for adults

  The Novavax vaccine is made of copies of the spike protein that coats the coronavirus, packaged into nanoparticles that to the immune system resemble a virus.

  Health

  Jul 13, 2022
• Advertisement
• U.S. FDA warns against heart inflammation risk from Novavax COVID-19 vaccine

  The U.S. Food and Drug Administration has raised concerns about a possible risk of heart inflammation from Novavax Inc's NVAX.OCOVID-19 vaccine.

  Health

  Jun 3, 2022
• Novavax COVID-19 vaccine approved for use in Canadian adults

  Novavax now joins Pfizer, Moderna, AstraZeneca and Johnson and Johnson as vaccine makers that have COVID-19 jabs approved for use in Canada.

  Health

  Feb 17, 2022
• Novavax starts early trials for combined flu and COVID-19 vaccine

  Novavax had said in May it expects seasonal influenza and COVID-19 combination vaccines to likely be critical in combating emerging COVID-19 variants.

  Science

  Sep 8, 2021
• Novavax says large study shows COVID-19 vaccine 90.4% effective

  Vaccine maker Novavax said Monday its shot was highly effective against COVID-19 and also protected against variants in a large, late-stage study in the U.S. and Mexico.

  Health

  Jun 14, 2021
• Novavax delays timeline for approval, production of COVID-19 vaccine to late 2021

  The Maryland-based company has repeatedly pushed back production forecasts and has struggled to access raw materials and equipment needed to make its vaccine.

  Health

  May 10, 2021
• Advertisement
• Novavax vaccine shows 51% efficacy in COVID-19 infections caused by B.1.351 variant

  However, the study did not provide data on efficacy of the Novavax COVID-19 vaccine in preventing severe disease or hospitalization.

  Health

  May 6, 2021
• Advertisement
• Novavax vaccine 96% effective against COVID-19, 86% against U.K. variant: study

  There were no cases of severe illness or deaths among those who got the vaccine, the company said.

  Canada

  Mar 12, 2021